These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31360179)

  • 21. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
    Husaini M; Biton Y; Stair B; Moss AJ; Biering-Sørensen T; Solomon S; McNitt S; Polonsky B; Zareba W; Barsheshet A; Kutyifa V
    Cardiol J; 2016; 23(4):437-45. PubMed ID: 27320956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Addition of a Defibrillator to Resynchronization Therapy Decreases Mortality in Patients With Nonischemic Cardiomyopathy.
    Doran B; Mei C; Varosy PD; Kao DP; Saxon LA; Feldman AM; DeMets D; Bristow MR
    JACC Heart Fail; 2021 Jun; 9(6):439-449. PubMed ID: 33992570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use and Outcomes of Dual Chamber or Cardiac Resynchronization Therapy Defibrillators Among Older Patients Requiring Ventricular Pacing in the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Borne RT; Masoudi FA; Curtis JP; Zipse MM; Sandhu A; Hsu JC; Peterson PN
    JAMA Netw Open; 2021 Jan; 4(1):e2035470. PubMed ID: 33496796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Applicability of a risk score for prediction of the long-term benefit of the implantable cardioverter defibrillator in patients receiving cardiac resynchronization therapy.
    Barra S; Looi KL; Gajendragadkar PR; Khan FZ; Virdee M; Agarwal S
    Europace; 2016 Aug; 18(8):1187-93. PubMed ID: 26566940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Left ventricular dimensions predict risk of appropriate shocks but not mortality in cardiac resynchronization therapy-defibrillator recipients with left bundle-branch block and non-ischemic cardiomyopathy.
    Adelstein EC; Schwartzman D; Jain S; Bazaz R; Wang NC; Saba S
    Europace; 2017 Oct; 19(10):1689-1694. PubMed ID: 27856539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy-defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis.
    Narducci ML; Biffi M; Ammendola E; Vado A; Campana A; Potenza DR; Iori M; Zanon F; Zacà V; Zoni Berisso M; Bertini M; Lissoni F; Bandini A; Malacrida M; Crea F
    Europace; 2018 Sep; 20(9):1475-1483. PubMed ID: 29186401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in predictors of implantable cardioverter-defibrillator therapies in patients with ischaemic and non-ischaemic cardiomyopathies.
    Darma A; Nedios S; Kosiuk J; Richter S; Doering M; Arya A; Rolf S; Sommer P; Hindricks G; Bollmann A
    Europace; 2016 Mar; 18(3):405-12. PubMed ID: 26056190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
    Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
    J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
    Verma A; Sarak B; Kaplan AJ; Oosthuizen R; Beardsall M; Wulffhart Z; Higenbottam J; Khaykin Y
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):320-9. PubMed ID: 19796352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
    Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
    Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes after atrioventricular node ablation and biventricular pacing in patients with refractory atrial fibrillation and heart failure: a comparison between non-ischaemic and ischaemic cardiomyopathy.
    Sohinki D; Ho J; Srinivasan N; Collins LJ; Obel OA
    Europace; 2014 Jun; 16(6):880-6. PubMed ID: 24525552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of intermittent atrial tachyarrhythmia on heart failure or death in cardiac resynchronization therapy with defibrillator versus implantable cardioverter-defibrillator patients: a MADIT-CRT substudy (Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy).
    Ruwald AC; Pietrasik G; Goldenberg I; Kutyifa V; Daubert JP; Ruwald MH; Jons C; McNitt S; Wang P; Zareba W; Moss AJ
    J Am Coll Cardiol; 2014 Apr; 63(12):1190-1197. PubMed ID: 24333490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcomes after Catheter Ablation of Ventricular Tachycardia in Dilated vs. Ischemic Cardiomyopathy.
    Chakarov I; Mueller J; Ene E; Berkovitz A; Sonne K; Nentwich K; Schupp T; Behnes M; Deneke T
    J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection and outcome of implantable cardioverter-defibrillator patients with and without cardiac resynchronization therapy: Comparison of 4384 patients from the German Device Registry to randomized controlled trials.
    Köbe J; Willy K; Senges J; Hochadel M; Kleemann T; Spitzer SG; Andresen D; Jehle J; Steinbeck G; Szendey I; Butter C; Brachmann J; Hoffmann E; Eckardt L
    J Cardiovasc Electrophysiol; 2022 Mar; 33(3):483-492. PubMed ID: 35028995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of early cardiac resynchronization therapy implantation in dilated cardiomyopathy patients with narrow QRS carrying lamin A/C mutation.
    Blich M; Darawsha W; Eyal A; Shehadeh F; Boulous M; Gepstein L; Suleiman M
    Am J Cardiovasc Dis; 2024; 14(1):47-53. PubMed ID: 38495409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.
    Leyva F; Taylor RJ; Foley PW; Umar F; Mulligan LJ; Patel K; Stegemann B; Haddad T; Smith RE; Prasad SK
    J Am Coll Cardiol; 2012 Oct; 60(17):1659-67. PubMed ID: 23021326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [ECG score to predict ICD therapies in patients with nonischemic cardiomyopathy and primary prophylactic CRT-D].
    Grett M; Christ M; Röing Gen Nölke JP; Trappe HJ
    Herzschrittmacherther Elektrophysiol; 2017 Mar; 28(1):48-53. PubMed ID: 28204917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischaemic cardiomyopathy implanted for primary prevention: the RELEVANT [Role of long dEtection window programming in patients with LEft VentriculAr dysfunction, Non-ischemic eTiology in primary prevention treated with a biventricular ICD] study.
    Gasparini M; Menozzi C; Proclemer A; Landolina M; Iacopino S; Carboni A; Lombardo E; Regoli F; Biffi M; Burrone V; Denaro A; Boriani G
    Eur Heart J; 2009 Nov; 30(22):2758-67. PubMed ID: 19567380
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.